ArticleJournal for immunotherapy of cancer2026

PARP inhibition combined with a T-cell receptor β chain-directed antibody fusion molecule drives polyclonal antitumor immunity and tumor regression.

Ginette Santiago-Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.